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A B S T R A C T
Obtaining reliable and reproducible high quality data in multicenter clinical research settings requires design of
optimal standard operating procedures. While the need for standardization in sample processing and data
analysis is well-recognized, the impact of sample handling in the pre-analytical phase remains underestimated.
We evaluated the impact of sample storage time (≈transport time) and temperature, type of anticoagulant, and
limited blood volume on reproducibility of flow cytometric studies.
EDTA and Na-Heparin samples processed with the EuroFlow bulk lysis protocol, stained and stored at 4 °C
showed fairly stable expression of cell surface markers and distribution of the major leukocyte populations for up
to 72 h. Additional sample fixation (1% PFA, Fix & Perm) did not have any beneficial effects. Blood samples
stored for <24 h at room temperature before processing and staining seemed suitable for reliable im-
munophenotyping, although losses in absolute cell numbers were observed. The major losses were observed in
myeloid cells and monocytes, while lymphocytes seemed less affected. Expression of cell surface markers and
population distribution were more stable in Na-Heparin blood than in EDTA blood. However, storage of Na-
Heparin samples was associated with faster decrease in leukocyte counts over time. Whole blood fixation
strategies (Cyto-Chex, TransFix) improved long-term population distribution, but were detrimental for expres-
sion of cellular markers. The main conclusions from this study on healthy donor blood samples were successfully
confirmed in EDTA clinical (patient) blood samples with different time delays until processing. Finally, we
recognized the need for adjustments in bulk lysis in case of insufficient blood volumes.
Despite clear overall conclusions, individual markers and cell populations had different preferred conditions.
Therefore, specific guidelines for sample handling should always be adjusted to the clinical application and the
main target leukocyte population.
1. Introduction
Standardized sample processing, immunostaining procedures, and
calibration of instruments assure quality and reproducibility of flow
cytometric data (Owens et al., 2000; Kalina et al., 2012). Still, limited
guidelines are available for sample handling in the pre-analytical phase.
Parameters such as sample volume, storage time and temperature, and
type of anticoagulant seem crucial for optimal data quality, reprodu-
cibility and correct data interpretation.
In multicenter studies transportation of samples is often required.
Whenever granulocytes are not studied (Lionetti et al., 1975) and se-
lective loss of leukocyte subsets can be afforded (Reimann et al., 2000),
batch shipment of cryopreserved mononuclear cells might be used.
However, if precise quantification and detailed immunophenotyping of
all leukocyte subsets is required, peripheral blood (PB) needs to be
analyzed fresh prior to any substantial sample manipulation. Whenever
sample collection and analysis cannot be performed at the same loca-
tion, either fresh blood or stained blood samples are shipped for central
data acquisition. Depending on the distance, availability of personnel
and equipment, such shipment may cause serious delays.
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Prolonged blood storage leads to selective loss of cell populations
with a short half-life time, such as eosinophils and neutrophils (Park
and Bochner, 2010; Summers et al., 2010). Additionally, biochemical
changes, such as decrease in pH, changes in blood gases (Kelman and
Nunn, 1966), alterations in the contents of amino acids, carbohydrates,
lipids and cofactors (Kamlage et al., 2018; Nishiumi et al.,2018), might
further influence cell viability. The magnitude of these changes partly
depends on the temperature (Tanner et al., 2002; Thavasu et al., 1992).
Ng et al. reported that certain monocytes and natural killer (NK) cell
subsets are relatively stable at 4 °C (Ng et al., 2012), while Hodge et al.
showed a delayed apoptosis of granulocytes in refrigerated blood (Ng
et al., 2012; Hodge et al., 1999). In contrast, lymphocyte stability is
affected by low temperature, with optimal temperature for T cells being
14–16 °C (Ekong et al., 1992). Thus, both time and temperature of
blood storage need to be optimized for specific research questions.
Reagents like Cyto-Chex, TransFix and formaldehyde extend the
storage time of whole blood prior to flow cytometric analysis (Ng et al.,
2012; Chow et al., 2005). However, they might have some unwanted
effects. Davis et al. and Ng et al. found that while Cyto-Chex is more
effective in preserving cell counts, TransFix is more potent in preserving
cell identity (Ng et al., 2012; Davis et al., 2011). The loss of signal
intensity, especially in Cyto-Chex, was further confirmed by others
(Schumacher, 2007).
The Fix & Perm reagent Kit (Nordic MUbio, Susteren, the
Netherlands), Becton Dickinson Perm/Wash buffer (BD Biosciences, San
Jose CA), paraformaldehyde (PFA), glutaraldehyde or ethanol are fre-
quently used to stabilize processed and labeled samples (Kalina et al.,
2012; Schmid et al., 1991; Gerner et al., 2008; Carayon and Bord, 1992;
Liu et al., 1992). Still, these reagents may affect the detection of cell
surface markers by reducing the availability of the targeted antigen
epitopes (Lal et al., 1988; Maecker et al., 2010) and thereby hamper
optimal discrimination between cell populations. So far, no extensive
comparative study of the impact of these techniques on the quality of
stained samples after storage has been performed.
Combining flow cytometry with functional assays may influence the
choice of anticoagulant. Ethylene diamine tetra-acetate (EDTA) is
generally preferred in immunophenotyping, but it retains calcium for
enzymatic reactions which hampers functional studies; thus, for the
latter assays EDTA should preferably be replaced by heparin (Kamlage
et al., 2018). Several studies have evaluated the impact of anticoagulant
on sample stability. Heparin was found superior to EDTA in preserving
granulocytes (Hodge et al., 1999), while data on lymphocyte stability
remains controversial (Nicholson and Green, 1993; Paxton et al., 1989).
So far, little is known about the impact of anticoagulant on the stability
of cellular markers over time.
Standardized protocols (e.g. the EuroFlow bulk lysis protocol
(Flores-Montero et al., 2017)) are designed for predefined large blood
volumes. If, for example in pediatric settings, sample volume is in-
sufficient, protocol adjustments might improve the quality of the final
data.
Here we evaluated the impact of different blood storage conditions
and potential protocol adjustments on the quality of flow cytometric
data in multicenter clinical research settings (Fig. 1). For this purpose
the highly standardized EuroFlow “primary immunodeficiency or-
ientation tube” (PIDOT) (van der Burg et al., 2019), which allows
identification of all major cell populations in blood, was used as a
model to assess stability of cells and cell surface markers in healthy and
clinical samples.
2. Materials and methods
2.1. Samples
PB samples were obtained from healthy adult volunteers after they
had given their informed consent to participate (n=15; m/f ratio: 5/
10; age range: 23–62 y, mean age: 36 y). K3EDTA blood collection tubes
(Vacuette®, Greiner Bio-One, Alphen aan den Rijn, the Netherlands)
were used in all experiments, unless indicated otherwise. To evaluate
the effect of anticoagulant on sample quality and stability, Na-Heparin
blood collection tubes (Vacuette®, Greiner Bio-One) were used in par-
allel.
2.2. Blood processing and staining with PIDOT
All PB samples were processed according to the EuroFlow bulk lysis
standard operating protocol (SOP) (available at www.EuroFlow.org). In
brief, up to 2ml of blood was incubated with 50ml of ammonium
chloride (NH4Cl) at room temperature (RT) on a roller bank to lyse non-
nucleated red blood cells. After a washing step, nucleated cells were
counted on an automated hematological analyzer (Sysmex XP-300,
Sysmex Europe GmbH, Norderstedt, Germany), and 2.5× 106 cells
were stained for 30min in the dark with the PIDOT antibody combi-
nation (Cytognos SL, Salamanca, Spain) according to the instructions of
the manufacturer (www.cytognos.com)(van der Burg et al., 2019). Fi-
nally, cells were incubated for 10min (in the dark; RT) with 2ml of BD
FACS™ Lysing Solution (BD Biosciences), washed once and re-sus-
pended in 200 μl PBS prior to acquisition. A liquid format of the anti-
body combination was used (van der Velden et al., 2017), unless in-
dicated otherwise. In the latter cases a dried version of PIDOT was used.
Previous studies showed similar performance in samples stained using
liquid and dried PIDOT (van der Velden et al., 2017).
In the experiments with limited sample volume, a modified version
of the bulk lysis protocol was used where 100 or 200 μl of K3EDTA PB
sample was lysed in 3ml or 50ml of NH4Cl without cell counting prior
to acquisition on the flow cytometer.
2.3. Storage of stained samples (delayed acquisition)
Bulk-lysed PB samples stained with the PIDOT antibody combina-
tion were acquired directly or stored at 4 °C for delayed acquisition (0 h,
6 h, 18 h, 24 h, 30 h, 42 h, 48 h, 66 h and 72 h). In addition, part of the
samples was treated with Reagent A of Fix & Perm® (F&P) or PFA
(Merck, Darmstadt, Germany) to evaluate the effect of additional
sample fixation on the stability of stained surface markers and leuko-
cyte subset distribution. Treatment with Reagent A (F&P) was per-
formed according to the manufacturer's protocol. In brief, after treat-
ment with 1× BD FACS™ Lysing Solution and a washing step, 100 μl of
sample was incubated with 100 μl of Reagent A for 15min in the dark
(RT). Afterwards, samples were washed and stored in 200 μl of PBS at
4 °C for up to 72 h. Treatment with PFA was performed in a comparable
way, except for the incubation that was performed on ice. After initial
evaluation of PFA concentration (0.5%, 1% and 2% final concentra-
tion), 1% PFA was used.
2.4. Storage of whole blood samples (delayed processing and staining)
To investigate the effect of prolonged blood storage on data quality,
K3EDTA and Na-Heparin blood samples were stored at RT or 4 °C for up
to 72 h prior to processing and staining. Additionally, treatment with
TransFix (Cytomark, Leeds, UK) and Cyto-Chex blood collection tubes
(Streck Cyto-Chex™, La Vista, NE) were evaluated.
TransFix was added to PB in K3EDTA collection tubes according to
manufacturer's protocol (Revision 3 US, 2016–11). Both storage at RT
(for up to 4 days) and at 4 °C (for up to 14 days) were investigated.
Cyto-Chex blood collection tubes were used according to manu-
facturer's protocol (Version 2017–02) and stored at RT for evaluation
for up to 14 days.
2.5. Evaluation of absolute cell numbers
Two alternative approaches were used to determine absolute cell
counts in (aged) K3EDTA and Na-Heparin blood samples. First, absolute
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leukocyte counts were measured on an automated hematological ana-
lyzer (Sysmex XP-300) at 0 h, 6 h, 12 h, 24 h, 30 h, 36 h, 48 h, 54 h, 60 h
and 72 h after blood drawing. Then, analyses were repeated with
Perfect-Count Microspheres™ (Cytognos) on BD LSRFortessa™ flow
cytometer according to the EuroFlow SOP (www.EuroFlow.org).
Leukocytes were discriminated based on the expression of CD45 (CD45-
OC515, Cytognos).
2.6. Evaluation of clinical samples
To extrapolate the results of the storage experiments to diagnostic
settings, flow cytometric data on 88 peripheral blood samples from
primary immunodeficiency (PID) suspected individuals were evaluated
retrospectively (age range: 0–79 y, mean age: 30 y). Flow cytometric
data were obtained in a diagnostic context and approval for inclusion in
the study was obtained by the Ghent University Hospital Ethics
Committee (approval 2016/1137). In the diagnostic setting, samples
were processed locally according to the EuroFlow guidelines. In all
cases K2EDTA (BD Vacutainer®, Becton Dickinson Benelux,
Erembodegem, Belgium) was used as anticoagulant, and whole blood
was stored at RT for variable time periods before analysis with PIDOT
(liquid format).
2.7. Flow cytometer set up and data acquisition
PIDOT stained samples were measured on FACSCanto™ II (BD
Biosciences) instruments while Perfect-Count tubes were measured on
LSRFortessa™ flow cytometer (BD Biosciences). Flow cytometers were
calibrated daily according to the EuroFlow guidelines. In short, pho-
tomultiplier tube (PMT) voltages of the flow cytometer were set using
BD™ Setup and Tracking (CS&T) beads (BD Biosciences) and SPHERO™
Rainbow calibration particles (Cytognos), as previously described)
(Kalina et al., 2012; Kalina et al., 2015).
2.8. Data analysis
Samples were mostly analyzed manually or manually checked after
automated analysis with the EuroFlow PIDOT reference database
(Infinicyt™ Software v2.0, Cytognos) with respect to both marker sta-
bility and distribution of the major cell populations. Most positive and
negative reference populations were defined as previously described
(van der Velden et al., 2017). For each reference population, mean
fluorescence intensity (MFI) was determined. A deviation of 30% from
the original MFI value (MFIbaseline) was set as the acceptance limit. The
difference compared to MFIbaseline was determined by the following
formula in which MFIx represents the MFI of a sample in a given con-
dition: (MFIbaseline−MFIx)/MFIbaseline) * 100. The distribution of a cell
population was calculated as its relative frequency in the sample after
excluding debris and doublets.
Determination of the degree of correlation between variables was
performed using a Spearman correlation, after assessment of the nor-
mality of the distribution using the Shapiro Wilks test. For all statistical
analyses the GraphPad Prism 8.0 software (GraphPad, San Diego, CA,
USA), was used.
3. Results
3.1. Stable expression of cell surface markers and distribution of major cell
populations after delayed acquisition of stained samples
The PIDOT SOP (Cytognos PIDOT manual: revision 16-02-2018)
recommends to acquire cells immediately after staining, or at most after
1 h of storage at 4 °C. To determine the effect of delayed acquisition of
stained samples, PIDOT tubes were analyzed fresh or after they had
been stored at 4 °C for 6 h, 18 h, 24 h, 30 h, 42 h, 48 h, 66 h and 72 h
(Fig. 2A).
The impact of sample storage on the expression of cell surface
markers was evaluated by analysis of their MFI on both positive and
negative reference populations (Supplemental Table 1, Fig. 2B). Most
markers remained stable on positive reference populations for up to
72 h with the exception of CD16+CD56 PE (>10% loss of MFI after
24 h), and TCRγδ PE-Cy7 (>10% loss of MFI after 18 h, >30% loss
after 48 h). Despite the stable MFI on positive reference populations,
background staining increased for most markers, in particular for
CD16+CD56 PE (>30% after 6 h), but in no case this hampered the
discrimination of cell populations stained with PIDOT.
The Automatic Population Separator (APS) tool, based on the
principal component analysis algorithms, was used to demonstrate
overall segregation of populations in the multidimensional space. With
the exception of neutrophils at 72 h, all medians of populations in aged
blood fell within one standard deviation (SD) line of the reference
baseline population, and outside of one standard deviation lines of
other populations (Fig. 2C). Although basophils, monocytes and plas-
macytoid dendritic cells (pDCs) were positioned closely together, they
were clearly separable in other APS views (not shown).
To evaluate which of the major lymphoid and myeloid populations



























Fig. 1. Critical decision steps involving the sample
pre-analytical phase in clinical trial design.
Depending on the design of the trial several deci-
sions need to be made concerning (1) the choice of
the blood collection tubes (anti-coagulant), (2) the
distribution of samples based on the minimal vo-
lumes required per assay, (3) the time and tem-
perature of sample transportation, and (4) storage of
processed samples prior to data acquisition and data
analysis.
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are the most affected by storage, their distribution was compared in
stained samples stored for different time periods (Supplemental
Table 2). Remarkably, the distribution of the major cell subsets re-
mained quite stable for up to 72 h (Supplemental Table 2, Fig. 2D). The
largest variation from baseline was observed for the eosinophils, mainly
due to substantial changes in one donor.
3.2. No beneficial effect of additional fixation of stained samples
The lysing solution utilized in the PIDOT SOP already contains a low
concentration of fixative (<15% formaldehyde and <50% diethylene
glycol in BD FACS™ Lysing Solution; 10× concentrated). To evaluate
whether usage of an additional fixation step would have a positive
impact on the quality of the data, freshly stained samples were treated
with 1% PFA or with Solution A from F&P and evaluated after 0 h, 6 h,
18 h, 24 h, 30 h, 42 h, 48 h, 66 h and 72 h storage at 4 °C (Fig. 2A).
Fixation with 1% PFA had no additional beneficial effect on the
stability of cell surface markers (Supplemental Table 1, Fig. 2B),
whereas treatment with Solution A of F&P mainly had detrimental ef-
fects such as decreased MFI values for CD45RA BV510, IgM PerCP-
Cy5.5 (>30%) and to a lesser extent for CD16+56 PE, CD4 PerCP-
Cy5.5, CD27 BV421 and TCRγδ PE-Cy7 (>10%). After the initial de-
crease in MFI, signal remained relatively stable over time. Moreover,
the discrimination among the distinct cell populations identified with
PIDOT was not hampered by the additional fixation step. Evaluation of
population phenotype in the APS view revealed that in stored samples
fixed with 1% PFA, aged neutrophils (>42 h), CD16+ monocytes
(<48 h) and NK cells (>66 h) showed the biggest variation from
baseline, deviating >1SD line of the reference population (Fig. 2C). F&
P treated samples stayed within 1SD of the reference population at all
times, but at the early time points fixed sample differed from baseline
more than unfixed stored samples. In both PFA and F&P-treated sam-
ples, all populations were clearly separable.
The distribution of cell populations in fixed samples should reflect
the distribution of the same cell populations in fresh samples, and re-
main stable over time. However, directly after fixation with 1% PFA,
the frequency of lymphocytes (B, T, NK cells) and CD16+ monocytes
decreased by >10% (Supplemental Table 2, Fig. 2D). Additionally, the
frequency of basophils and eosinophils decreased by >10% after 6 h.
These changes were mainly compensated by the relative increase in
neutrophils. Afterwards, the distribution of populations remained stable
over time. Fixation with Solution A resulted in a similar pattern, but
with less impact on T cells and NK cells (Supplemental Table 2).
3.3. Hampered expression of cell surface markers and gradual loss of
myeloid cells after prolonged whole blood storage
To mimic the delay caused by sample transportation, PB collected in
EDTA tubes was analyzed at 0 h or stored as whole blood either at RT or
at 4 °C, for delayed processing, staining and acquisition at 24 h, 30 h,
42 h, 48 h and 72 h (Fig. 3A).
In order to assess the impact of prolonged blood storage on detec-
tion of cell surface markers, MFIs of individual markers were analyzed
on both positive and negative reference populations. Irrespective of
storage temperature, already at 24 h most markers showed >10% de-
crease in MFI on the positive reference cell populations, together with
an increased unspecific staining on negative cells (Supplemental
Table 1, Fig. 3B). At RT the MFI signal was the least stable for CD27
BV421 and TCRγδ PE-Cy7 (>30% decrease in MFI from 42 h onwards),
while at 4 °C the most affected markers were CD3 APC and TCRγδ PE-
Cy7 (>30% decrease in MFI after 24 h). Despite all the above, most
populations could still be identified for up to 72 h, but discrimination
among them was clearly impaired over time.
In the APS view, (CD16+) monocytes, NK cells, neutrophils and B
cells deviated >1SD of the reference population when blood was stored
at RT from >30 h (Fig. 3C). Whereas in PB stored at 4 °C the phenotype
of B cells, T cells, and pDCs was impaired at later time points (>24 h),
CD16+ monocytes and NK cells showed limited deviation from base-
line.
Several blood cell populations, mainly those of myeloid origin, have
half-life times equal or shorter than 24 h (6–8 h for neutrophils, 18 h for
eosinophils, 1–2 d for monocytes) (Park and Bochner, 2010; Summers
et al., 2010; Ziegler-Heitbrock, 2014). Indeed, in blood stored for 24 h
at RT the frequency of eosinophils was reduced by 55% and the fre-
quency of CD16+ monocytes by 27% (Fig. 3D, Supplemental Table 2).
Although the relative loss of neutrophils reached only 9%, a substantial
part of these latter cells already showed early signs of apoptosis (lower
FSC, SSC, CD45 and CD16 expression, without a clear separation from
the viable population). The most overrepresented populations were
long-living pDCs (+20%) and lymphocytes, with B cells being more
overestimated (+53%) than T cells (+29%) and NK cells (+11%). In
blood stored at 4 °C for 24 h, both eosinophils and neutrophils were
underestimated by around 11%, which was mainly compensated by a
relative increase in both lymphocytes and monocytes (Supplemental
Table 2). Thus, monocytes were better preserved at 4 °C than at RT.
Nevertheless, samples stored at RT were overall more stable than
samples stored at 4 °C.
Cell death not only influences the distribution of cell populations in
a sample, but also their absolute counts. Interestingly, at later time
points, analysis on Sysmex XP-300 was more robust than analysis with
the Perfect-Count Microspheres™, which showed progressive loss of
cells of up to 17% (RT) and 25% (4 °C) at 72 h (Fig. 3E). These differ-
ences may be caused by less extensive sample handling or the less
stringent exclusion of dying cells on Sysmex XP-300.
3.4. Hampered expression of cell surface markers and initial changes in the
distribution of cell populations after whole blood fixation
Two alternative whole blood fixation strategies were evaluated in
parallel: Transfix for up to 4 days at RT and up to 14 days at 4 °C and
Cyto-Chex for up to 14 days at RT (Fig. 4A). Both fixation methods
resulted in an initial decrease in MFI (>10%) for approximately half of
the markers tested (Supplemental Table 1, Fig. 4B). In all cases the most
affected markers were CD16+CD56 PE and CD27 BV421 (>30% MFI
loss), followed by CD8 FITC and TCRγδ PE-Cy7 (>10% decreased MFI
values). Additionally, TransFix led to changes in signal intensity of
CD45RA BV510 (>10% increase at 4 °C) and IgM PerCP-Cy5-5 (>10%
decrease at RT), and Cyto-Chex fixation was associated with decreased
signal intensity of CD4 PerCP-Cy5-5 (>10%). Further decrease in MFI
over time occurred for all markers in Cyto-Chex tubes and for most
markers in TransFix-treated samples. Decreased MFIs, increased back-
ground and affected cell scatter hampered discrimination of several cell
Fig. 2. Longitudinal analysis of stained samples stored without or with additional fixative. Peripheral blood samples were collected into K3EDTA tubes stained and
stored at 4 °C for delayed acquisition. Additional stained samples were treated with 1% paraformaldehyde (PFA) or Fix&Perm Solution A (F&P) directly after staining
and prior to the storage at 4 °C, n≥3. (A) Flow chart showing the different storage conditions tested in this experiment (B) Mean fluorescence intensity (MFI) of
selected cell surface markers on positive and negative reference populations. Each point indicates a mean value from ≥3 individual experiments. Dashed lines depict
a 30% deviation from the MFI value at baseline (fresh sample without an additional fixative). (C) Individual populations from different time points separated by an
automated population separator (APS) and visualized in 2D projections of the first and third principal components. Each dot represents a median value and each
dashed line represent 1 standard deviation line of the indicated population at t=0h. Data of one representative donor is shown. Obtained data were analyzed with
Infinicyt™ Software. (D) Changes in the frequency of individual cell populations over time relative to baseline.
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Fig. 3. Longitudinal analysis of blood sam-
ples stored in K3EDTA tubes. Peripheral
blood samples were collected into K3EDTA
tubes and stored either at RT or at 4 °C for
delayed staining. All results were compared
to freshly stained K3EDTA samples, n≥ 3.
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ference populations. Each point indicates a
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MFI value at baseline. (C) Individual popu-
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by an automated population separator (APS)
and visualized in 2D projections of the first
and third principal components. Each dot
represents a median value and each dashed
line represent 1 standard deviation line of the
indicated population at t= 0 h. Data of one
representative donor is shown. Obtained data
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Changes in the frequency of individual cell
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subsets. Finally, the number of cell doublets and debris was increased,
most likely due to an increased cell death and as a side effect of fixation
(data not shown).
TransFix-treated samples stored at RT showed the best preservation
of population phenotype of all whole blood-fixed samples.
Nevertheless, in the APS view basophils, neutrophils and eosinophils at
multiple time points deviated more than 1SD from their reference po-
pulation (Fig. 4C). In TransFix-treated samples stored at 4 °C, myeloid
cells were heavily affected from the start. Already at 24 h time point
neutrophils, CD16+ monocytes and NK cells deviated >1SD from
baseline samples. Deviations in eosinophils, monocytes and basophils
showed a gradual increase in time. Evaluation of Cyto-Chex treated
samples revealed a hampered identification of pDCs, neutrophils, ba-
sophils, CD16+ monocytes and eosinophils at most time points. Thus,
whole blood fixation seemed to have the biggest detrimental impact on
cells of myeloid origin.
Although at most of the time points populations of cells in Cyto-
Chex and TransFix samples cluster together in the multidimensional
space, the initial deviation from baseline samples render them un-
suitable for comparison with baseline samples and use for detailed
immunophenotyping.
Both Cyto-Chex and TransFix affected the relative distribution of
multiple cell populations. Lymphocytes and monocytes were over-
represented at the expense of granulocytes, similar to what was ob-
served in blood samples stored at 4 °C (Supplemental Table 2, Fig. 4D).
Decrease in neutrophil numbers was especially prominent in samples
treated with TransFix. After these initial changes, the distribution of
cell populations remained relatively stable over time. Overall, samples
stored at RT performed slightly better than samples stored at 4 °C.
3.5. Good performance of PIDOT in Na-Heparin blood
Heparin is often the anticoagulant of choice when im-
munophenotyping needs to be combined with functional assays. To
compare EDTA and Na-Heparin blood samples, Na-Heparin and EDTA
anticoagulated blood was stained directly and stored at 4 °C for ac-
quisition at 0 h, 24 h, 30 h and 48 h. Additionally, samples in Na-
Heparin tubes were stored at RT or at 4 °C for delayed staining and
acquisition at 24 h, 30 h and 48 h (Fig. 5A).
Stained and stored EDTA and Na-Heparin samples performed
equally well with regards to marker stability and cell population dis-
tribution (Fig. 5B–D, Supplemental Table 3, Supplemental Table 4).
None of the markers in samples collected in Na-Heparin tubes, besides
CD16+56 PE showed a> 10% decrease in MFI signal, and the in-
crease in background staining was limited (>30% for only
CD16+CD56 PE and CD27 BV421). None of the analyzed cell popu-
lations were clearly over- or underestimated over time. When looking at
a representative donor in the APS plot, baseline samples showed a
smaller standard deviation in directly stained Na-Heparin samples
compared to directly stained EDTA samples. For neutrophils and
CD16+ monocytes, >1SD difference was seen after 24 h and 48 h,
respectively. Nevertheless, stored samples closely represented baseline
samples (Fig. 5C).
Samples stored at RT in Na-Heparin tubes prior to staining showed
stable expression of most of the evaluated cell surface markers (none
showed decreased MFI values of >30%) and outperformed samples
stored at RT in EDTA tubes (Supplemental Table 1). Sample storage at
4 °C had a more detrimental effect on marker expression in both EDTA
and Na-Heparin. While CD3 APC and CD27 BV421 performed better in
Na-Heparin tubes, CD8 FITC was more stable in EDTA.
Na-Heparin samples stored at RT showed virtually no deviations
>1SD in the multidimensional space up to 48 h of PB storage. Na-
Heparin samples stored at 4 °C showed deviations >1SD from 30 h
onwards for NK cells, B cells and neutrophils (Fig. 5C).
The relative distribution of distinct cell populations was more stable
when samples were stored at RT, and Na-Heparin tubes were associated
with more stable results than EDTA tubes (Fig. 5D). Up to 24 h no major
deviations were observed in Na-Heparin samples stored at RT, while at
later time points lymphocytes (mainly T cells), monocytes and baso-
phils were slightly overrepresented at the expense of eosinophils,
CD16+ monocytes and neutrophils. These changes were more promi-
nent in Na-Heparin blood stored at 4 °C, where almost all cell popula-
tions deviated from baseline by >10% already at 30 h. Again, lym-
phocytes (mainly B cells), monocytes and basophils were
overrepresented at the expense of neutrophils.
In contrast to the expression of cell surface markers and the dis-
tribution of cell populations, absolute leukocyte numbers were less
stable in samples stored in Na-Heparin than in EDTA (Fig. 5E). After
24 h, in samples measured by Perfect-Count Microspheres™, absolute
cell counts decreased by ~40% in Na-Heparin and by ~20% in EDTA.
Remarkably, all samples were stable over time when measured on
Sysmex XP-300 except for Na-Heparin samples stored at 4 °C. Na-He-
parin samples stored at 4 °C showed a strong initial drop in absolute cell
counts in all donors (>30% after 12 h), followed by gradual recovery
from 30 h onwards.
3.6. Bulk lysis protocol should be adjusted for limited sample volume
Bulk lysis SOP is optimized for 1.5–2ml of blood, which results in
more than the 2.5×106 cells required for PIDOT. As different lysis
protocols may impact sample properties like scatter and marker ex-
pression, it is recommended to use the same protocol for all samples
that are compared to one another, especially when automated analysis
is used. In case too little sample volume is available for bulk lysis, the
protocol may need to be adjusted. To evaluate the procedure for limited
blood volumes, 100 μl and 200 μl of blood were lysed either with 50ml
of NH4Cl (bulk lysis SOP) or 3ml of NH4Cl (blood/NH4Cl ratio similar
to official EuroFlow SOP; Supplemental Table 5) and stained with
PIDOT. If a reduced NH4Cl volume was used, lysis was performed di-
rectly in the staining tube to minimize cell loss during transfer of
sample between tubes.
If the original blood/NH4Cl ratio was maintained, the distribution of
cell populations in small volume samples was more comparable to the
distribution of such cell populations in samples processed according to
the SOP. In small volume samples lysed with 50ml of NH4Cl most B-cell
subsets were underestimated by >20%, mainly in favor of granulocytes
and monocytes. In all tested conditions, the fluctuations of plasma cell
percentages were large (>50%), most likely due to the small popula-
tion size at the detection limit of the method.
Fig. 4. Longitudinal analysis of blood samples stored in K3EDTA tubes with a whole blood fixative. Peripheral blood samples were collected into K3EDTA tubes,
treated with TransFix and stored for delayed staining either at RT or at 4 °C or collected into Cyto-Chex blood collection tubes and stored for delayed staining at RT.
All results were compared to freshly stained K3EDTA samples, n≥3. (A) Flow chart showing different storage conditions tested in this experiment (B) Mean
fluorescence intensity (MFI) of selected cell surface markers on positive and negative reference populations. Each point indicates a mean value from ≥3 individual
experiments. Dashed lines depict a 30% deviation from the MFI value at baseline (fresh sample without an additional fixative). (C) Individual populations from
different time points separated by an automated population separator (APS) and visualized in 2D projections of the first and third principal components. Each dot
represents a median value and each dashed line represent 1 standard deviation line of the indicated population at t= 0 h. Data of one representative donor is shown.
Obtained data were analyzed with Infinicyt™ Software. (D) Changes in the frequency of individual cell populations over time relative to baseline.
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3.7. Prolonged storage of diagnostic samples affects data analysis
To evaluate the impact of sample storage in diagnostic settings, 88
EDTA blood samples from PID-suspected individuals were stored for up
to 8 days at RT and analyzed with PIDOT. As all samples were sent for
routine diagnostics, no baseline measurements were available. For
analysis purposes samples were anonymized and divided into five ca-
tegories based on storage duration: 0–12 h, 12–24 h, 24–48 h, 48–72 h
and >72 h.
As in the whole blood storage experiments with healthy controls,
most markers showed >10% decrease in MFI on the positive reference
population already 12–24 h after collection (Supplemental table 6,
Fig. 6). In accordance with the previous findings in PB stored at RT, the
most dramatic decrease in signal was observed for TCRγδ PE-Cy7 and
CD27 BV421, which showed >30% and 28% decrease in MFI in sam-
ples acquired >48 h after drawing, respectively. Furthermore, control
and diagnostic samples shared some common features regarding re-
lative changes in population distribution over time, i.e. a gradual loss of
eosinophils and NK cells (Fig. 6, Supplemental Table 7). Although in
both control and diagnostic samples most populations could be iden-
tified in aged blood, the situation in PID-suspected individuals was
complicated by the unknown diagnosis. Therefore, the absence or an
aberrant phenotype of a given population could be attributed either to
prolonged sample storage or to the underlying disease.
4. Discussion
Complex sample logistics in multicenter clinical studies require
careful alignment of working procedures among participating labora-
tories. Extra challenges are caused by limited sample volume (e.g. in
case of infants or young children) and the need of sample transportation
to another (e.g. reference) laboratory. Here we evaluated several cri-
tical steps in the process of obtaining high quality flow cytometry data
from peripheral blood samples. We showed how the choice of antic-
oagulant influences the stability of cell surface markers and cell po-
pulations, and tested a range of possibilities to preserve whole blood
and stained samples for delayed acquisition. These results were trans-
lated to clinical settings by retrospective analysis of routine diagnostic
samples. Finally, we recognized the need for adjusting working proce-
dures in case of insufficient sample volumes.
Enumeration of white blood cells is one of the most frequently re-
quested routine diagnostic tests. Here we evaluated two alternative
strategies to determine absolute cell counts: flow cytometry-based
Perfect-Count Microsphere™ measurements and the Sysmex XP-300
hematological analyzer. Overall, results obtained with Sysmex XP-300
in aged blood better reflected results from fresh samples. Analysis with
Perfect-Count Microspheres™ was preceded by sample treatment for
10min with NH4Cl. This lysis step can have a detrimental effect on the
–already vulnerable- aging cells which then become classified as debris
or dead cells rather than viable cells; alternatively speed of analysis and
electronic-digital signal processing, together with different rates of
doublet formation might contribute to explain such differences.
Furthermore, the potential inclusion or exclusion of apoptotic cells by
different counting methods could result in different blood cell counts.
Irrespective of the blood storage temperature, measurement of Na-
Heparin samples resulted in lower absolute cell counts than those ob-
tained for EDTA anticoagulated samples. Therefore, whenever long-
itudinal analyses are required, or subtle changes in cell numbers are
expected, it is crucial to always use the same blood collection tubes,
preferably EDTA tubes if samples will be processed immediately
(<24–30 h).
Reliable analysis of absolute cell counts by Sysmex XP-300 was not
possible in Na-Heparin samples stored at 4 °C. For these samples leu-
kocyte numbers showed an apparently rapid initial decrease followed
by a slow gradual recovery after 24 h. These changes were positively
correlated with the platelet counts (Spearman correlation P< .0001,
correlation coefficient of 0.65). A likely explanation is that in Na-
Heparin samples stored at 4 °C platelets become activated and start to
form aggregates (Zucker and Borrelli, 1954; White and Krivit, 1967)
including platelet-leukocyte aggregates. This formation and disin-
tegration may explain fluctuations in the absolute leucocyte count.
Total white blood cell numbers can be reliably determined in a
limited volume of blood. However, if infrequent cell populations need
to be quantified, analysis might reach the detection limit. Here, we
stained 2.5× 106 cells (resulting in acquisition of ~1–1.5×106 cells)
and observed that small populations like plasma cells, eosinophils and
specific T-cell subsets showed a greater variation than larger cell po-
pulations, implying that the enumeration of less represented cell po-
pulations has to be more critically assessed. Increasing the number of
cells evaluated will most likely improve accurate quantitation of such
rare cells. As stated by Oldaker et al., and proven by Theunissen et al.,
and Flores Montero et al., detection of low represented abnormal cell
populations is possible as long as an adequate number of events is ac-
quired (Flores-Montero et al., 2017; Oldaker et al., 2016; Theunissen
et al., 2017).
In fact, the limit of detection of one or more cell populations be-
comes an important problem when limited blood volumes are available.
Here we found that the distribution of populations analyzed in the small
volume samples better reflects the distribution of populations in large
volume samples when the volumes of reagent are adjusted to maintain
the same blood/reagents volume ratio. Fewer transfer steps between
tubes in the protocol with adjusted blood/reagents volume may further
influence better preservation of initial population distribution.
Consequently, reagent volumes and protocols need to be adapted to
sample volumes. In any case, the total number of acquired white blood
cells should always be acknowledged to indicate the reliability of the
data.
Populations of cells are defined based on the presence or absence of
specific markers and their expression levels (especially of importance if
these are modulated during cell activation and/or maturation) (Sallusto
et al., 1998; Nopp et al., 2000; Bachmann et al., 2005; Reddy et al.,
2004). Therefore, each marker should not only provide a proper dis-
crimination between strong and dim positive cells and between positive
and negative cells, but it should also provide an adequate resolution to
detect more subtle changes. Here we confirmed and extended previous
observations (Ng et al., 2012; Hodge et al., 1999; Ekong et al., 1992;
Chow et al., 2005; Davis et al., 2011; Schumacher, 2007; Lal et al.,
1988; Maecker et al., 2010; Nicholson and Green, 1993; Paxton et al.,
1989) by showing that the type of anticoagulant, storage time, storage
conditions and treatment all had an impact on marker expression levels
Fig. 5. Longitudinal analysis of blood samples collected into Na-Heparin tubes. Peripheral blood samples were collected into Na-Heparin tubes, stained and acquired
directly or stored at 4 °C for delayed acquisition. Additional samples were collected into Na-Heparin tubes and stored either at RT or at 4 °C for delayed staining. All
results were compared to freshly stained K3EDTA samples of the same donors, n≥ 3. In 1 donor, the PIDOT in dried format was used, in all others, the liquid format
was used for staining. (A) Flow chart showing different storage conditions tested in this experiment (B) Mean fluorescence intensity (MFI) of selected cell surface
markers on positive and negative reference populations. Each point indicates a mean value from ≥3 individual experiments. Dashed lines depict a 30% deviation
from the MFI value at baseline (fresh sample without an additional fixative). (C) Individual populations from different time points separated by an automated
population separator (APS) and visualized in 2D projections of the first and third principal components. Each dot represents a median value and each dashed line
represent 1 standard deviation line of the indicated population at t= 0 h. Data of one representative donor is shown. Obtained data were analyzed with Infinicyt™
Software. (D) Changes in the frequency of individual cell populations over time relative to baseline. (E) Changes in leukocyte count over time relative to baseline as
measured by two independent methods.
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and background staining. Similar findings on the impact of antic-
oagulant on sample stability have recently been published by Kárai
et al. in the context of bone marrow and PB processing (Kárai et al.,
2018).
None of the two tested anticoagulants (Na-Heparin, EDTA) had a
clear advantage over the other with regard to stability of marker ex-
pression levels. However, individual markers performed better in one of
the conditions. Therefore, if MFIs are to be compared, it is crucial to be
consistent with the choice of anticoagulant.
For most markers the resolution of signal decreased over time. The
decrease in signal and increase in background staining was more pro-
minent in stored whole blood than in stored processed and stained
samples. This is likely because the signal intensity can be influenced by
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Fig. 6. Impact of sample storage on diagnostic samples collected in K3EDTA tubes.
Peripheral blood samples were collected into K3EDTA tubes and stored at RT until staining (n=88). Mean age and range per group: 0–12 h (20.1; 1–67.4), 12–24 h
(23.0; 0.4–71.3), 24–48 h (36.5; 0.4–78.8), 48–72 h (39.9; 5.9–68.7), 72 h+ (28.6; 1.2–76.8) (A) Mean fluorescence intensity (MFI) of selected cell surface markers
on positive and negative reference populations. Each point indicates a mean value of all diagnostic samples collected within that timeframe (n≥11). Dashed lines
depict a 30% deviation from the MFI value from the samples acquired 0–12 h after collection. (B) Changes in the frequency of individual cell populations over time
relative to the samples acquired 0–12 h after collection.
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internalization of markers due to e.g. apoptosis or (in)activation (Reddy
et al., 2004; Dransfield et al., 1994). Furthermore, sample (including
whole blood) fixation (Solution A from F&P, Cyto-Chex, TransFix) had a
negative impact on marker expression. In these circumstances the most
prominent loss of signal occurred directly after addition of a fixative,
possibly due to conformational changes of the antibody targeted epi-
topes or impact of the fixative on the fluorochromes (McCarthy et al.,
1994).
Certain fluorochromes, e.g. some of the tandem-dyes, are known to
be less stable (Hulspas et al., 2009). Despite a broad range of antibodies
assessed, we have not observed antibodies conjugated with any specific
dye to be more affected. At the same time, we found that antibodies
with lower affinity for the antigen, such as TCRγδ, were especially
sensitive to prolonged sample storage. This is in line with what has been
reported by Davis et al., who showed that CD4 PE conjugates from
different clones showed great variability in both avidity and antibody
stability (Davis et al., 1998) and by Van der Velden et al., who showed
that TCRγδ PE-Cy7 showed greater variability when used in different
formats (freeze-dried or liquid antibodies) (van der Velden et al., 2017).
In whole blood samples the largest differences in cell distribution
were caused by progressive cell death (mainly granulocytes), which
appeared to be associated with both changes in the cell phenotype and
an increase in doublets and debris. Although whole blood fixation had a
detrimental effect on the relative distribution of distinct cell popula-
tions directly after treatment, it stabilized the relative distribution
afterwards, making this condition more beneficial at the later time
points. Thus, if blood cannot be processed within 24–30 h, and the
distribution of cell populations is of primary interest, whole blood
fixation might be an option. However, we would not recommend it for
general immunophenotyping. Of note, it has been reported that PB
fixation may preserve leukocyte counts compared to untreated PB
(Springer et al., 1999; Canonico et al., 2004). Again, here we show that
additional fixation of processed samples provides better results than
fixation of whole blood samples.
Processing of diagnostic samples can be delayed by transportation
as well as by personnel and equipment availability. This can have
several consequences for the outcome of flow cytometric analysis. First,
we showed in healthy controls that, depending on the storage condi-
tions, absolute cell counts can decrease by up to 40% already 24 h after
collection. Since absolute cell count is one of the diagnostic criteria for
immunodeficiencies, cell loss in aged samples can affect proper diag-
nosis. Secondly, several immunodeficiencies are characterized by the
absence or reduced number of cell populations or their aberrant phe-
notype (van der Burg et al., 2019; van Zelm et al., 2006). A recent study
by van der Burg et al. showed reduced numbers of memory B cells in
confirmed SCID patients. The markers used in PIDOT to separate
memory B cells from pre-germinal center cells are mainly CD27 and
IgM. Thus, the observed decrease in CD27 BV421 and increased back-
ground in the PerCP-Cy5.5 channel (which harbors both IgM and CD4)
can eventually hamper discrimination of memory B cells. Analogical
problem can arise in identification of TCRγδ+ cells, as TCRγδ PE-Cy7
was one of the most storage-affected markers, and lack of these cells can
be associated with immune deficiency. Thus, prolonged storage
(>24 h) of diagnostic samples should be avoided and, if not possible,
they should be evaluated critically, keeping in mind that changes may
be attributed to sample aging.
In this study we used a <30% deviation from baseline MFI as a
measure of marker stability. In many cases, samples could be reliably
analyzed by experienced personnel despite greater signal changes. This
was at least in part based on the software used for data analysis
(Infinicyt™ Software v2.0, Cytognos), which allows for simultaneous
multidimensional gating rather than 2-dimensional consecutive gating.
In this multidimensional approach changes in expression of cellular
markers over time were absorbed by other markers in such a way that
population separation was still possible. Recently, a database has been
released for automated analysis of PIDOT (Infinicyt™ Software 2.0,
Cytognos). Although during the construction of a database high quality
samples are required (Lhermitte et al., 2018), it would be of great in-
terest to evaluate how aged and differently treated samples can be run
through such a database.
5. Concluding remarks
This intricate set of data presented here was based on the analysis of
a single antibody combination: PIDOT. Therefore, it cannot provide
universal guidelines. Still, certain conclusions can be drawn about what
can and should not be done in the pre-analytical phase of multicenter
clinical trials:
• Delay from blood collection to blood processing should be mini-
mized, especially in a diagnostic setting.
• PB samples stored for <24 h at RT seem suitable for reliable im-
munophenotyping, although losses in absolute cell numbers should
be taken into account.
• PB samples stored for 24–48 h at RT may be used for im-
munophenotyping, but results will be less reliable. Again, losses in
absolute cell numbers should be taken into account.
• In whole PB samples, most populations are more stable when stored
in Na-Heparin than in EDTA tubes at RT.
• However, storage of processed and stained samples is usually more
beneficial than storage of whole blood.
• B and T cells are the most stable populations, followed by NK cells,
whereas myeloid cells and monocytes are more sensitive to storage.
Thus, based on cell type of interest, different delays are acceptable.
• The impact of anticoagulant and potential fixation steps on the ex-
pression of individual cell markers varied significantly; thus, it is
crucial to be consistent in the use of anticoagulant, storage time and
temperature.
• Any deviations from standard operating procedures should be re-
corded.
• When determining absolute counts, minimize storage or aim for
consistent delays. Be consistent with the method used. In our ex-
perience an automated hematological analyzer is more stable than
flow cytometric determination of absolute counts.
Specific recommendations for individual types of cells are sum-
marized in Supplemental Fig. 1.
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.jim.2019.06.007.
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